Related Experiment Video
Updated: Feb 27, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
Structural basis of divergent cyclin-dependent kinase activation by Spy1/RINGO proteins
Denise A McGrath1, Bre-Anne Fifield2, Aimee H Marceau1
1Department of Chemistry and Biochemistry, University of California, Santa Cruz, CA, USA.
Abstract:
Cyclin-dependent kinases (Cdks) are principal drivers of cell division and are an important therapeutic target to inhibit aberrant proliferation. Cdk enzymatic activity is tightly controlled through cyclin interactions, posttranslational modifications, and binding of inhibitors such as the p27 tumor suppressor protein. Spy1/RINGO (Spy1) proteins bind and activate Cdk but are resistant to canonical regulatory mechanisms that establish cell-cycle checkpoints. Cancer cells exploit Spy1 to stimulate proliferation through inappropriate activation of Cdks, yet the mechanism is unknown. We have determined crystal structures of the Cdk2-Spy1 and p27-Cdk2-Spy1 complexes that reveal how Spy1 activates Cdk. We find that Spy1 confers structural changes to Cdk2 that obviate the requirement of Cdk activation loop phosphorylation. Spy1 lacks the cyclin-binding site that mediates p27 and substrate affinity, explaining why Cdk-Spy1 is poorly inhibited by p27 and lacks specificity for substrates with cyclin-docking sites. We identify mutations in Spy1 that ablate its ability to activate Cdk2 and to proliferate cells. Our structural description of Spy1 provides important mechanistic insights that may be utilized for targeting upregulated Spy1 in cancer.
Insights
Spy1 proteins activate cyclin-dependent kinases (Cdks) in cancer cells, driving proliferation. Structural analysis reveals Spy1’s unique mechanism, offering new therapeutic targets for cancer treatment.
Area of Science:
- Molecular Biology
- Structural Biology
- Cancer Research
Background:
- Cyclin-dependent kinases (Cdks) regulate cell division but are often dysregulated in cancer.
- Spy1/RINGO (Spy1) proteins activate Cdks but evade normal cell-cycle control.
- The mechanism by which Spy1 activates Cdks and its role in cancer proliferation are poorly understood.
Purpose of the Study:
- To elucidate the structural mechanism by which Spy1 activates Cdk2.
- To understand why Spy1-Cdk complexes are resistant to inhibition by p27.
- To identify potential therapeutic strategies targeting Spy1 in cancer.
Main Methods:
- X-ray crystallography to determine the structures of Cdk2-Spy1 and p27-Cdk2-Spy1 complexes.
- Site-directed mutagenesis to identify key residues in Spy1 function.
- Cell proliferation assays to assess the impact of Spy1 mutations.
Main Results:
- Spy1 binding induces structural changes in Cdk2, bypassing the need for activation loop phosphorylation.
- Spy1 lacks a cyclin-binding site, explaining its resistance to p27 inhibition and lack of substrate specificity.
- Mutations in Spy1 were identified that abolish Cdk2 activation and cellular proliferation.
Conclusions:
- Spy1 activates Cdk2 through a unique mechanism involving structural remodeling.
- The structural insights into Spy1-Cdk interactions provide a basis for developing targeted cancer therapies.
- Targeting Spy1 offers a promising strategy to inhibit aberrant proliferation in cancers that overexpress Spy1.
Related Concept Videos
Positive Regulator Molecules
Positive Regulator Molecules
Inhibition of Cdk Activity
The Contractile Ring
A small GTPase, RhoA, controls the function and assembly of the contractile ring. RhoA belongs to the Ras superfamily of proteins. The activation of formins by RhoA promotes...
S-Cdk Initiates DNA Replication
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...

